GO:0006213 pyrimidine nucleoside metabolic process: Biosynthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006213 (pyrimidine nucleoside metabolic process) describes all chemical reactions and pathways involving pyrimidine nucleosides, which are pyrimidine bases covalently bonded to ribose or deoxyribose.
• Pyrimidine nucleosides such as uridine and cytidine are central to RNA synthesis, nucleotide salvage, and cellular energy metabolism.
• Metabolic engineering of microbial systems enables large-scale production of pyrimidine nucleosides for pharmaceutical and nutraceutical applications.
• Pyrimidine nucleoside analogs are cornerstone agents in cancer chemotherapy and antiviral therapy.
• Bacterial wobble modifications of tRNAs that decode NNA codons depend on pyrimidine nucleoside metabolism, linking this pathway to translation fidelity.
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting the causal roles of pyrimidine nucleoside metabolic genes in health and disease [1,2].
Description
Pyrimidine nucleoside metabolic process (GO:0006213) encompasses the chemical reactions and pathways involving any pyrimidine nucleoside, a family of organic molecules consisting of a pyrimidine base covalently bonded to ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside). This process is fundamental to nucleotide homeostasis, nucleic acid synthesis, and cellular energy balance, and it is conserved from bacteria to humans [1,3]. The term includes both de novo biosynthesis and salvage pathways that interconvert pyrimidine bases, nucleosides, and nucleotides. Researchers study GO:0006213 because dysregulation of pyrimidine nucleoside metabolism is implicated in cancer, viral infections, and metabolic disorders [2,3]. Pyrimidine nucleoside analogs such as 5-fluorouracil and cytarabine are widely used in cancer treatment, and their efficacy depends on the metabolic machinery that activates or degrades them. In microbial systems, metabolic engineering of pyrimidine nucleoside pathways has enabled the production of uridine, cytidine, and related compounds for pharmaceutical use. Understanding the enzymes, transporters, and regulatory circuits that govern pyrimidine nucleoside metabolism is therefore critical for drug development, synthetic biology, and precision medicine [1,2,3]. This article provides a comprehensive overview of the ontology term, its molecular players, disease relevance, and experimental strategies for functional interrogation.
pyrimidine nucleoside metabolic process At A Glance
| GO ID | GO:0006213 |
|---|---|
| GO term | pyrimidine nucleoside metabolic process |
| Ontology | biological_process |
| Synonym | pyrimidine metabolic process; pyrimidine metabolism; pyrimidine nucleoside metabolism |
| Major function | Synthesis, salvage, interconversion, and degradation of pyrimidine nucleosides (e.g., uridine, cytidine, thymidine) for nucleic acid synthesis and cellular metabolism [1,3] |
| Key enzymes | Uridine phosphorylase, uridine kinase, cytidine deaminase, thymidine phosphorylase, and nucleoside transporters [1,3] |
| Pathway context | Includes de novo pyrimidine biosynthesis and salvage pathways |
| Disease relevance | Cancer chemotherapy, antiviral therapy, and metabolic disorders [2,3] |
| Model organisms | Escherichia coli, Saccharomyces cerevisiae, mammalian cell lines [1,4] |
What Is GO:0006213?
GO:0006213, pyrimidine nucleoside metabolic process, is defined as the chemical reactions and pathways involving any pyrimidine nucleoside, one of a family of organic molecules consisting of a pyrimidine base covalently bonded to ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside). In practical terms, it covers the synthesis, interconversion, salvage, and degradation of pyrimidine nucleosides such as uridine, cytidine, thymidine, and their deoxy counterparts [1,3]. The term is a biological process and includes enzymatic steps catalyzed by kinases, phosphorylases, deaminases, and nucleoside transporters.
Why Is pyrimidine nucleoside metabolic process Important in Cell Biology?
Pyrimidine nucleoside metabolic process is essential for maintaining the cellular pool of nucleotides required for DNA and RNA synthesis, energy transfer, and glycosylation reactions [1,3]. Its dysregulation contributes to cancer progression and chemoresistance, and it is the target of numerous anticancer and antiviral nucleoside analogs. Moreover, microbial production of pyrimidine nucleosides via metabolic engineering offers a sustainable route for manufacturing pharmaceutical intermediates. Understanding this process at the molecular level is therefore vital for drug discovery, synthetic biology, and personalized medicine [1,2,3].
• Provides precursors for DNA and RNA synthesis, including uridine, cytidine, and thymidine [1,3].
• Enables salvage pathways that recycle pyrimidine nucleosides from dietary sources and turnover.
• Serves as the activation route for anticancer and antiviral nucleoside analogs.
• Supports tRNA wobble modifications that affect translation fidelity in bacteria.
• Is a target for metabolic engineering to produce nutraceuticals and pharmaceuticals.
• Links to mitochondrial function and energy metabolism through pyrimidine nucleotide pools.
• Plays a role in immune modulation and gut microbiome-host interactions via uridine metabolism.
• Contributes to the biosynthesis of nucleoside antibiotics in Streptomyces and other bacteria [6,8].
• Offers opportunities for CRISPR-based functional genomics in cancer and metabolic diseases.
• Is conserved across species, making model organisms valuable for mechanistic studies [1,4].
What Happens During pyrimidine nucleoside metabolic process?
De Novo Pyrimidine Biosynthesis
In simple terms: The cell builds pyrimidine rings from scratch using simple molecules like glutamine and aspartate.
De novo pyrimidine biosynthesis begins with the formation of carbamoyl phosphate and proceeds through a series of enzymatic steps to produce uridine monophosphate (UMP), the first pyrimidine nucleotide. Key enzymes include carbamoyl phosphate synthetase II, aspartate transcarbamoylase, and dihydroorotate dehydrogenase. UMP is subsequently converted to other pyrimidine nucleosides and nucleotides, including cytidine and thymidine derivatives. This pathway is tightly regulated to match cellular demand for nucleic acid synthesis.
Salvage and Interconversion Pathways
In simple terms: The cell recycles existing pyrimidine nucleosides instead of making new ones from scratch.
Salvage pathways recover pyrimidine nucleosides from extracellular sources or from nucleic acid turnover. Uridine phosphorylase and thymidine phosphorylase cleave nucleosides to free bases, which can be reutilized. Uridine kinase and cytidine kinase phosphorylate nucleosides to nucleotides. These reactions are critical for maintaining intracellular nucleotide pools and for activating nucleoside analog drugs [2,3].
Nucleoside Transport and Compartmentalization
In simple terms: Pyrimidine nucleosides must be transported into cells and between cellular compartments.
Nucleoside transporters (e.g., equilibrative and concentrative nucleoside transporters) mediate the uptake of pyrimidine nucleosides across the plasma membrane. Inside the cell, nucleosides and nucleotides are distributed among the cytosol, mitochondria, and nucleus. Mitochondrial pyrimidine metabolism is essential for mitochondrial DNA replication and function. Transport and compartmentalization ensure that nucleosides are available where they are needed.
Catabolism and Excretion
In simple terms: Excess pyrimidine nucleosides are broken down and excreted.
Pyrimidine nucleosides can be catabolized to free bases, which are further degraded to water-soluble products such as beta-alanine and beta-aminoisobutyrate. This catabolic arm prevents accumulation of toxic intermediates and provides carbon and nitrogen for other metabolic pathways. Inborn errors in pyrimidine catabolism can lead to metabolic disorders, highlighting the importance of this process.
Integration with Nucleotide and Energy Metabolism
In simple terms: Pyrimidine nucleoside metabolism is connected to broader cellular energy and redox networks.
Pyrimidine nucleoside metabolism intersects with glycolysis, the pentose phosphate pathway, and mitochondrial oxidative phosphorylation [1,3]. For example, dihydroorotate dehydrogenase is a mitochondrial enzyme that couples pyrimidine biosynthesis to the electron transport chain. This integration ensures that pyrimidine production is coordinated with cellular energy status and redox balance [1,3].
Key Genes Involved in GO:0006213 pyrimidine nucleoside metabolic process
The following genes and proteins are central to pyrimidine nucleoside metabolic process, based on published literature [1,2,3,4,6,8].
| Gene | Major Role | Research Relevance |
|---|---|---|
| UMPS | Catalyzes the conversion of orotate to UMP in de novo pyrimidine biosynthesis | Target for cancer therapy and metabolic engineering |
| CAD | Multifunctional enzyme complex that initiates de novo pyrimidine biosynthesis | Regulated by phosphorylation and linked to cell proliferation |
| DHODH | Mitochondrial enzyme that oxidizes dihydroorotate to orotate | Target for immunosuppressive and anticancer drugs |
| UCK2 | Uridine-cytidine kinase 2 phosphorylates uridine and cytidine to UMP and CMP | Activates nucleoside analogs in cancer cells |
| CMPK1 | UMP-CMP kinase phosphorylates UMP and CMP to UDP and CDP | Essential for nucleotide salvage and activation of prodrugs |
| UPP1 | Uridine phosphorylase 1 cleaves uridine to uracil and ribose-1-phosphate | Modulates uridine homeostasis and drug sensitivity |
| TYMP | Thymidine phosphorylase catalyzes thymidine to thymine and deoxyribose-1-phosphate | Angiogenic factor and target for cancer therapy |
| CDA | Cytidine deaminase converts cytidine to uridine and deoxycytidine to deoxyuridine | Determines sensitivity to cytarabine and gemcitabine |
| SLC29A1 | Equilibrative nucleoside transporter 1 mediates cellular uptake of pyrimidine nucleosides | Influences drug bioavailability and resistance |
| SLC28A1 | Concentrative nucleoside transporter 1 transports pyrimidine nucleosides | Tissue-specific expression affects drug targeting |
| NME1 | Nucleoside diphosphate kinase 1 transfers phosphate groups to nucleoside diphosphates | Involved in nucleotide pool maintenance and metastasis suppression |
| RRM1 | Ribonucleotide reductase subunit M1 converts ribonucleotides to deoxyribonucleotides | Target for gemcitabine and other anticancer agents |
| RRM2 | Ribonucleotide reductase subunit M2 catalyzes deoxyribonucleotide synthesis | Cell cycle-regulated and target for cancer therapy |
| TK1 | Thymidine kinase 1 phosphorylates thymidine in the salvage pathway | Biomarker for cell proliferation and cancer |
| TK2 | Thymidine kinase 2 phosphorylates thymidine in mitochondria | Mutations cause mitochondrial DNA depletion syndromes |
| DCTD | Deoxycytidylate deaminase converts dCMP to dUMP | Balances nucleotide pools for DNA synthesis |
| TYMS | Thymidylate synthase converts dUMP to dTMP | Target of 5-fluorouracil in cancer chemotherapy |
| GART | Phosphoribosylglycinamide formyltransferase in purine biosynthesis | Indirectly linked to pyrimidine metabolism via one-carbon pools |
How Is pyrimidine nucleoside metabolic process Regulated?
Pyrimidine nucleoside metabolic process is regulated at multiple levels, including transcriptional control of biosynthetic enzymes, allosteric feedback inhibition by downstream nucleotides, and post-translational modifications. For example, CAD is activated by phosphorylation and regulated by MAPK and mTOR signaling pathways in response to growth factors. Uridine phosphorylase and thymidine phosphorylase are induced by inflammatory cytokines and hypoxia, linking pyrimidine metabolism to tumor microenvironment and immune responses. Additionally, nucleoside transporter expression is regulated by differentiation and stress signals, affecting drug uptake. These regulatory mechanisms ensure that pyrimidine nucleoside pools are matched to cellular demand for nucleic acid synthesis and energy metabolism [1,3].
pyrimidine nucleoside metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TYMS | Cancer chemoresistance to 5-fluorouracil | Knockout and point mutation in cancer cell lines |
| CDA | Cytarabine resistance in leukemia | Knockout and overexpression in leukemia models |
| TK2 | Mitochondrial DNA depletion syndrome | Knock-in of patient mutations in iPSCs |
| DPYD | 5-fluorouracil toxicity | Knockout in hepatocyte-like cells |
| UCK2 | Nucleoside analog activation in cancer | Overexpression and knockout in tumor xenografts |
Cancer and Chemoresistance
Altered pyrimidine nucleoside metabolism is a hallmark of many cancers, supporting rapid proliferation and influencing sensitivity to nucleoside analog drugs such as 5-fluorouracil, cytarabine, and gemcitabine. Overexpression of uridine phosphorylase or cytidine deaminase can confer resistance by degrading or inactivating these drugs, while high thymidylate synthase levels reduce 5-fluorouracil efficacy. Targeting these metabolic enzymes with CRISPR-based knockout models can reveal causal mechanisms and guide combination therapies.
Mitochondrial DNA Depletion Syndromes
Mutations in genes involved in mitochondrial pyrimidine nucleoside salvage, such as TK2 and DGUOK, cause mitochondrial DNA depletion syndromes characterized by myopathy, hepatopathy, and neurological impairment. These disorders underscore the importance of pyrimidine nucleoside metabolism for mitochondrial genome maintenance and energy production.
Viral Infections and Antiviral Therapy
Many antiviral drugs are pyrimidine nucleoside analogs that require activation by host or viral kinases. For example, cytidine analogs such as lamivudine and emtricitabine are used against HIV and hepatitis B, and their efficacy depends on cellular nucleoside metabolism. Studying pyrimidine nucleoside metabolic enzymes can inform the design of next-generation antivirals.
Inborn Errors of Pyrimidine Metabolism
Deficiencies in pyrimidine catabolic enzymes, such as dihydropyrimidine dehydrogenase, can cause severe toxicity to 5-fluorouracil and lead to neurological symptoms. These rare disorders highlight the clinical importance of pyrimidine nucleoside metabolic pathways and the need for genetic testing before drug administration.
From pyrimidine nucleoside metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of UMPS impair de novo pyrimidine biosynthesis? | CRISPR knockout in HEK293T or HCT116 cells |
| Does a specific point mutation in DHODH alter enzymatic activity? | CRISPR point mutation knock-in in cancer cell lines |
| Can overexpression of UCK2 sensitize cells to cytidine analogs? | CRISPR overexpression in resistant cell lines |
| How does TK2 mutation affect mitochondrial DNA maintenance? | Knock-in of patient mutations in iPSC-derived myotubes |
| What is the role of CDA in gemcitabine resistance? | Knockout and rescue in pancreatic cancer cells |
| Can metabolic engineering boost uridine production in microbes? | CRISPR knockout of competing pathways in E. coli |
How to Study the pyrimidine nucleoside metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of pyrimidine nucleosides and nucleotides | Profiling metabolic changes in cancer cells |
| Enzyme activity assay | Catalytic activity of metabolic enzymes | Validating CRISPR mutants |
| CRISPR knockout screen | Genes required for drug sensitivity or resistance | Identifying targets for combination therapy |
| RNA-seq | Transcriptional changes in metabolic pathways | Studying regulation by hypoxia or oncogenes |
| Proteomics | Protein expression and post-translational modifications | Mapping signaling to metabolism |
| Nucleoside transport assay | Uptake of radiolabeled or fluorescent nucleosides | Characterizing transporter function |
| Mitochondrial DNA copy number assay | Mitochondrial genome maintenance | Modeling TK2 deficiency |
| Microbial fermentation | Production of pyrimidine nucleosides | Metabolic engineering for industrial use |
Metabolomics and Nucleoside Quantification
Liquid chromatography-mass spectrometry (LC-MS) and HPLC are used to quantify pyrimidine nucleosides and their metabolites in cells, plasma, and tissues. These methods enable researchers to measure flux through de novo and salvage pathways and to assess the impact of genetic perturbations [1,3].
Enzyme Activity Assays
In vitro enzyme assays using recombinant proteins or cell lysates measure the catalytic activity of uridine phosphorylase, thymidine phosphorylase, cytidine deaminase, and kinases [1,2]. These assays are essential for validating the functional consequences of mutations identified in patient samples or CRISPR screens.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout and activation screens can identify genes that modulate sensitivity to pyrimidine nucleoside analogs or that regulate nucleoside pools. Such screens have uncovered novel regulators of drug resistance and metabolic dependencies in cancer.
Transcriptomics and Proteomics
RNA-seq and quantitative proteomics reveal expression changes in pyrimidine metabolic enzymes under different conditions, such as hypoxia or drug treatment [1,3]. These approaches help build regulatory networks and identify biomarkers [1,3].
How CRISPR Can Be Used to Study GO:0006213 pyrimidine nucleoside metabolic process
Knockout
CRISPR knockout of genes such as UMPS, CAD, or UCK2 enables researchers to determine their essentiality for pyrimidine nucleoside metabolism and cell proliferation [1,2]. Knockout cell lines can be used to study drug sensitivity, metabolic flux, and compensatory pathways.
Point Mutation
CRISPR point mutation knock-in allows precise modeling of patient-derived mutations in enzymes like DHODH or TK2, revealing how specific amino acid changes affect catalytic activity and cellular phenotypes [1,3].
Knock-in
Knock-in of tagged or reporter constructs (e.g., GFP or luciferase) at endogenous loci facilitates real-time monitoring of enzyme expression and localization in response to metabolic cues.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate levels of enzymes such as CDA or TYMS to study their role in drug resistance and metabolic reprogramming.
How EDITGENE Supports pyrimidine nucleoside metabolic process Research
Researchers studying pyrimidine nucleoside metabolic process-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as drug resistance or metabolic flux. EDITGENE provides a comprehensive suite of CRISPR-based services to enable these functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for pyrimidine nucleoside metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TYMP Knockout HEK293 Cell Line | EDJ-KQ2212 | Human | 1890 | Details Get a Quote |
| TYMP Knockout A-549 Cell Line | EDJ-KQ22468 | Human | 1890 | Details Get a Quote |
| TYMP Knockout HCT 116 Cell Line | EDJ-KQ22469 | Human | 1890 | Details Get a Quote |
| TYMP Knockout HeLa Cell Line | EDJ-KQ22470 | Human | 1890 | Details Get a Quote |
| NT5C3A Knockout HEK293 Cell Line | EDJ-KQ51298 | Human | 51251 | Details Get a Quote |
| NT5C3A Knockout HeLa Cell Line | EDJ-KQ56260 | Human | 51251 | Details Get a Quote |
| NT5C3A Knockout A-549 Cell Line | EDJ-KQ64749 | Human | 51251 | Details Get a Quote |
| NT5C3A Knockout HCT 116 Cell Line | EDJ-KQ73195 | Human | 51251 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About pyrimidine nucleoside metabolic process
What is pyrimidine nucleoside metabolic process?
It is the set of chemical reactions and pathways involving pyrimidine nucleosides, which are pyrimidine bases bonded to ribose or deoxyribose, as defined by GO:0006213.
What genes are involved in pyrimidine nucleoside metabolic process?
Key genes include UMPS, CAD, DHODH, UCK2, CMPK1, UPP1, TYMP, CDA, SLC29A1, and TK1, among others [1,2,3].
Why is pyrimidine nucleoside metabolism important in cancer?
It activates or degrades nucleoside analog drugs and supports the high nucleotide demand of proliferating cancer cells, influencing chemoresistance.
What diseases are linked to pyrimidine nucleoside metabolic process?
Cancer, mitochondrial DNA depletion syndromes, viral infections, and inborn errors of pyrimidine metabolism are linked to this process [2,3].
How can CRISPR be used to study pyrimidine nucleoside metabolism?
CRISPR knockout, point mutation knock-in, and overexpression models allow researchers to test the causal role of specific metabolic genes in cellular phenotypes and drug responses [1,2].
What are the main enzymes in pyrimidine nucleoside salvage?
Uridine phosphorylase, thymidine phosphorylase, uridine kinase, cytidine kinase, and cytidine deaminase are key salvage enzymes [1,3].
How is pyrimidine nucleoside metabolism regulated?
It is regulated by transcriptional control, allosteric feedback, and signaling pathways such as MAPK and mTOR, as well as by substrate availability [1,3].
What methods are used to study pyrimidine nucleoside metabolism?
LC-MS metabolomics, enzyme activity assays, CRISPR screens, RNA-seq, and proteomics are commonly used [1,2,3].
Can pyrimidine nucleosides be produced by microbial fermentation?
Yes, metabolic engineering of microbial systems enables production of pyrimidine nucleosides for pharmaceutical and nutraceutical applications.
What is the role of pyrimidine nucleoside metabolism in mitochondria?
It provides precursors for mitochondrial DNA synthesis and is essential for mitochondrial function; defects cause depletion syndromes.
Conclusion
Pyrimidine nucleoside metabolic process (GO:0006213) is a fundamental biological pathway that sustains nucleic acid synthesis, energy metabolism, and cellular responses to drugs and stress [1,3]. Its dysregulation is implicated in cancer, mitochondrial diseases, and antiviral resistance, making it a rich area for therapeutic intervention [2,3]. Advances in CRISPR-based functional genomics and metabolic engineering continue to illuminate the enzymes and regulatory networks that control this process [1,2]. By leveraging precise knockout, knock-in, and overexpression models, researchers can dissect the causal roles of individual genes and translate these findings into new treatments and biotechnological applications [1,2]. EDITGENE is committed to supporting these efforts with high-quality CRISPR services and bioinformatics solutions.
References
- 1. Zhang X et al.. 2024. Production of pyrimidine nucleosides in microbial systems via metabolic engineering: Theoretical analysis research and prospects.. Biotechnol Adv 75:108419 PMID: 39053562
- 2. Galmarini CM et al.. 2003. Pyrimidine nucleoside analogs in cancer treatment.. Expert Rev Anticancer Ther 3(5):717-28 PMID: 14599094
- 3. Yamamoto T et al.. 2011. Biochemistry of uridine in plasma.. Clin Chim Acta 412(19-20):1712-24 PMID: 21689643
- 4. Nilsson EM et al.. 2019. Bacterial wobble modifications of NNA-decoding tRNAs.. IUBMB Life 71(8):1158-1166 PMID: 31283100
- 6. Niu G et al.. 2015. Nucleoside antibiotics: biosynthesis, regulation, and biotechnology.. Trends Microbiol 23(2):110-9 PMID: 25468791
- 8. McErlean M et al.. 2021. Identification and characterization of enzymes involved in the biosynthesis of pyrimidine nucleoside antibiotics.. Nat Prod Rep 38(7):1362-1407 PMID: 33404015
